We believe that this is not the case because in our previous studies where we block neurogenesis using pathological hallmarks of Alzheimer’s disease and Kynurenic acid, interleukin-4 was sufficient to restore the neurogenic capacity at the later time points of the culture (Papadimitriou et al., 2018). This evidence concerns the gene IL4 and early-onset autosomal dominant Alzheimer disease.